Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia
Waldenström macroglobulinemia (WM)/lymphoplasmacytic lymphoma (LPL) is a non-Hodgkin-type B cell lymphoma. Here, the authors identify two risk loci for WM/LPL in a two-stage GWAS involving a family-oversampling approach and provide evidence for a functional role of the non-coding SNP rs116446171.
Guardado en:
Ejemplares similares
-
Macroglobulinemia de Waldenström. Experiencia de 15 años en el Hospital del Salvador, Santiago, Chile
por: Cardemil,Daniela, et al.
Publicado: (2019) -
Waldenström macroglobulinaemia presenting as tingling ulcers on the feet
por: Isabelle Fischer, et al.
Publicado: (2013) -
Waldenström macroglobulinemia: biology, genetics, and therapy
por: Paludo J, et al.
Publicado: (2016) -
Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults
por: Andrew L. Young, et al.
Publicado: (2016) -
Ziprasidone in the treatment of mania in bipolar disorder
por: Stephen E Nicolson, et al.
Publicado: (2007)